Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas
{{output}}
The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of patients.... ...